Göttgens K W A, Smeets R R, Stassen L P S, Beets G, Breukink S O
Department of Surgery, Maastricht University Medical Centre, Post box 5800, 6202 AZ, Maastricht, The Netherlands,
Int J Colorectal Dis. 2015 May;30(5):583-93. doi: 10.1007/s00384-014-2091-8. Epub 2014 Dec 10.
Perianal fistulas, and specifically high perianal fistulas, remain a surgical treatment challenge. Many techniques have, and still are, being developed to improve outcome after surgery. A systematic review and meta-analysis was performed for surgical treatments for high cryptoglandular perianal fistulas.
Medline (Pubmed, Ovid), Embase and The Cochrane Library databases were searched for relevant randomized controlled trials on surgical treatments for high cryptoglandular perianal fistulas. Two independent reviewers selected articles for inclusion based on title, abstract and outcomes described. The main outcome measurement was the recurrence/healing rate. Secondary outcomes were continence status, quality of life and complications.
The number of randomized trials available was low. Fourteen studies could be included in the review. A meta-analysis could only be performed for the mucosa advancement flap versus the fistula plug, and did not show a result in favour of either technique in recurrence or complication rate. The mucosa advancement flap was the most investigated technique, but did not show an advantage over any other technique. Other techniques identified in randomized studies were seton treatment, medicated seton treatment, fibrin glue, autologous stem cells, island flap anoplasty, rectal wall advancement flap, ligation of intersphincteric fistula tract, sphincter reconstruction, sphincter-preserving seton and techniques combined with antibiotics. None of these techniques seem superior to each other.
The best surgical treatment for high cryptoglandular perianal fistulas could not be identified. More randomized controlled trials are needed to find the best treatment. The mucosa advancement flap is the most investigated technique available.
肛周瘘,尤其是高位肛周瘘,仍然是外科治疗的一项挑战。许多技术已经并且仍在不断发展,以改善手术效果。我们对高位隐窝腺源性肛周瘘的外科治疗进行了系统评价和荟萃分析。
检索Medline(PubMed、Ovid)、Embase和Cochrane图书馆数据库,查找关于高位隐窝腺源性肛周瘘外科治疗的相关随机对照试验。两名独立的评审员根据标题、摘要和所描述的结果选择纳入的文章。主要结局指标是复发/愈合率。次要结局指标是控便状态、生活质量和并发症。
可用的随机试验数量较少。14项研究可纳入本综述。仅对黏膜推进皮瓣与肛瘘栓进行了荟萃分析,在复发率或并发症发生率方面未显示出对任何一种技术有利的结果。黏膜推进皮瓣是研究最多的技术,但未显示出优于任何其他技术的优势。随机研究中确定的其他技术包括挂线治疗、药物挂线治疗、纤维蛋白胶、自体干细胞、岛状皮瓣肛门成形术、直肠壁推进皮瓣、括约肌间瘘管结扎术、括约肌重建术、保留括约肌挂线术以及与抗生素联合的技术。这些技术似乎都不比其他技术更优越。
无法确定高位隐窝腺源性肛周瘘的最佳外科治疗方法。需要更多的随机对照试验来找到最佳治疗方法。黏膜推进皮瓣是现有研究最多的技术。